<DOC>
	<DOCNO>NCT00182338</DOCNO>
	<brief_summary>Patients kidney failure dialysis much high risk develop cardiovascular disease compare general population . Recently , two large study show increase amount dialysis decrease cardiovascular disease . It know retain much fluid lead high blood pressure thicken heart wall . Peritoneal dialysis method home dialysis allow dialysis patient autonomy independence . This study measure blood level protein call N-BNP measure extent body fluid machine call bioimpedance analyzer . This device administer undetectible electric current distributes throughout total body water . The relationship test clinical presence volume expansion assess . In addition , extent total body fluid 's impact heart attack , heart failure stroke determine .</brief_summary>
	<brief_title>Evaluation Volume Status Peritoneal Dialysis Patients</brief_title>
	<detailed_description>Patients end-stage renal disease ( ESRD ) high risk general population develop premature cardiovascular disease ; reason complex . Two recent randomize controlled trial peritoneal dialysis patient demonstrate target patient high dialysis clearance value associate reduction mortality . It known patient peritoneal dialysis likely volume expand , develop leave ventricular hypertrophy , inadequate blood pressure relative patient hemodialysis . As result increase attention role fluid management reduce risk develop congestive heart failure adverse cardiovascular event peritoneal dialysis patient . Extracellular fluid volume total body water accurately assess multi-frequency bioimpedance analysis ( BIA ) . Estimation volume expansion measure natriuretic peptide N-BNP produce cardiac tissue response ventricular wall stretch also use . The purpose study determine whether volume status , measure BIA N-BNP level , correlate clinical volume assessment , cardiovascular outcome , peritoneal membrane transport property marker inflammation serum albumin C-reactive protein .</detailed_description>
	<mesh_term>Inflammation</mesh_term>
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<criteria>Adult patient , 18 year age old , end stage renal disease peritoneal dialysis minimum 3 month Peritonitis previous 3 month ; history bilateral low limb amputation ; inability provide inform consent ; presence pacemaker defibrillator ; anticipate death transplant within 6 month recruitment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2011</verification_date>
	<keyword>cardiovascular outcome</keyword>
	<keyword>congestive heart failure</keyword>
	<keyword>Peritoneal Membrane transport property</keyword>
	<keyword>Arterial stiffening</keyword>
	<keyword>Inflammatory marker</keyword>
</DOC>